IDXX

553.32

1.32% 7.23

Dopo l'orario di chiusura: 553.32

Idexx Laboratories Inc (IDXX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché IDXX Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$546.09

Aprire:

$553.725

Volume 24 ore:

570.33K

Relative Volume:

0.88

Capitalizzazione di mercato:

$43.59B

Reddito:

$4.45B

Utile/perdita netta:

$1.10B

Rapporto P/E:

40.71

EPS:

13.591

Flusso di cassa netto:

$1.06B

1 W Prestazione:

-5.68%

1M Prestazione:

-2.49%

6M Prestazione:

-12.85%

1 anno Prestazione:

-13.25%

Intervallo 1D:

$549.75

$559.46

Intervallo di 1 settimana:

$538.20

$584.15

Portata 52W:

$518.55

$769.98

Idexx Laboratories Inc Stock (IDXX) Company Profile

Nome

Idexx Laboratories Inc

Settore

Healthcare (1072)

Industria

Diagnostics & Research (49)

Telefono

(207) 556-0300

Indirizzo

ONE IDEXX DRIVE, WESTBROOK, ME

Dipendente

11,000

Cinguettio

@idexx

Prossima data di guadagno

2026-08-04

Ultimi documenti SEC

IDXX's Discussions on Twitter

Compare IDXX vs TMO, DHR, NTRA, A

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
IDXX Idexx Laboratories Inc	553.32	43.02B	4.45B	1.10B	1.06B	13.59
TMO Thermo Fisher Scientific Inc	589.04	216.49B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	199.58	142.45B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	311.69	45.29B	2.50B	-226.32M	71.51M	-1.6412
A Agilent Technologies Inc	148.44	41.93B	7.23B	1.41B	1.09B	4.979

Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-04-15	Iniziato	Citigroup	Neutral
2025-12-09	Iniziato	Barclays	Overweight
2025-10-31	Aggiornamento	Stifel	Hold → Buy
2025-10-01	Iniziato	UBS	Neutral
2025-08-05	Reiterato	BTIG Research	Buy
2025-07-01	Iniziato	Jefferies	Buy
2024-12-02	Iniziato	Leerink Partners	Outperform
2024-07-25	Iniziato	BTIG Research	Buy
2024-01-30	Downgrade	Piper Sandler	Overweight → Neutral
2023-12-07	Iniziato	Exane BNP Paribas	Outperform
2023-12-04	Aggiornamento	Cleveland Research	Neutral → Buy
2023-08-02	Downgrade	Atlantic Equities	Overweight → Neutral
2022-07-25	Downgrade	Stifel	Buy → Hold
2022-07-21	Aggiornamento	Goldman	Neutral → Buy
2022-07-12	Iniziato	Piper Sandler	Overweight
2022-05-05	Downgrade	BofA Securities	Buy → Neutral
2022-02-08	Iniziato	Atlantic Equities	Overweight
2021-11-18	Iniziato	Morgan Stanley	Overweight
2021-08-05	Ripresa	Credit Suisse	Outperform
2021-07-12	Downgrade	Guggenheim	Buy → Neutral
2021-02-17	Iniziato	Barclays	Overweight
2019-09-09	Iniziato	Goldman	Neutral
2019-05-23	Iniziato	Guggenheim	Buy
2018-11-02	Reiterato	BofA/Merrill	Buy
2018-05-07	Reiterato	Stifel	Buy
2018-01-16	Iniziato	Piper Jaffray	Overweight
2017-08-23	Aggiornamento	BofA/Merrill	Neutral → Buy
2017-07-28	Aggiornamento	CL King	Neutral → Buy
2017-02-03	Downgrade	Feltl & Co.	Hold → Sell
2016-09-29	Ripresa	BofA/Merrill	Neutral
2016-08-16	Reiterato	Stifel	Buy
2016-08-03	Aggiornamento	Northcoast	Sell → Neutral
2016-07-20	Reiterato	Canaccord Genuity	Buy
2016-04-19	Reiterato	Canaccord Genuity	Buy
2016-04-01	Iniziato	CL King	Neutral
2016-03-21	Reiterato	Stifel	Buy
2016-02-04	Iniziato	Credit Suisse	Outperform
2015-10-29	Reiterato	Stifel	Buy
2015-08-28	Downgrade	Raymond James	Outperform → Mkt Perform
2015-08-13	Reiterato	Stifel	Buy
2015-07-23	Reiterato	Canaccord Genuity	Buy

Mostra tutto

Idexx Laboratories Inc Borsa (IDXX) Ultime notizie

03:56 AM

IDEXX Laboratories stock holds above the mid-$540s as valuation stays demanding - AD HOC NEWS

03:56 AM

02:03 AM

IDXX (IDEXX Laboratories) Cash From Discontinued Investing Activities : $0 Mil (TTM As of Jun. 2026) - GuruFocus

02:03 AM

06:02 AM

Plato Investment Management Ltd Takes $1.48 Million Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat

06:02 AM

05:24 AM

IDEXX Labs Executing, But Valuation Continues To Weigh On That Execution (NASDAQ:IDXX) - Seeking Alpha

05:24 AM

Aug 17, 2026

Weekly Recap: AI diagnostics expansion and Barclays trims target to $710 - TradingView

Aug 17, 2026

Aug 16, 2026

Transamerica Large Core ESG's IDEXX Laboratories Inc(IDXX) Holding History - GuruFocus

Aug 16, 2026

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Aug 16, 2026

Aug 15, 2026

IDEXX Laboratories (IDXX) Institutional Ownership 2026 - MarketBeat

Aug 15, 2026

Aug 14, 2026

IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors - MarketWatch

Aug 14, 2026

IDEXX Laboratories Targets $45B Pet Diagnostics Opportunity With AI, Cancer Tests - MarketBeat

Aug 14, 2026